XOMA
XOMA
NASDAQ · Biotechnology

Xoma Royalty Corporation

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$40.17
-4.05 (-9.16%)
As of Aug 8, 10:26 PM ET ·
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Buy 6 67%
Hold 3 33%
Sell 0 0%
Price Target
Analyst Price Target -0.4% upside
Low Target $30.13
Average Target $40.02
High Target $66.99
Current Price $40.17
Current
$40.17
Target
$40.02
$30.13 $40.02 avg $66.99
Scenario Analysis
Bear Case
$30.13
-25.0%
Low target
Base Case
$40.02
-0.4%
Avg target
Bull Case
$66.99
+66.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$45.22
-11.2% from high
52-Week Low
$22.29
+80.2% from low
Target vs 52W High
$40.02
-11.5% vs high
Next Earnings Report
Aug 11, 2026
1d
tomorrow
EPS Est: $0.18
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%